Overnight versus 24 Hours of Continuous Subcutaneous Insulin Infusion as Supplement to Oral Antidiabetic Drugs in Type 2 Diabetes

BACKGROUND: Basal continuous subcutaneous insulin infusion (CSII) therapy at a fixed rate may effectively improve glycemic control in patients with type 2 diabetes when oral antidiabetic treatment fails. Regimens of simple constant subcutaneous delivery of insulin may provide theoretical advantages...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Parkner, Tina, Laursen, Torben, Chen, Jian-Wen, Møller, Marianne K., Thomsen, Henrik F., Jørgensen, Christina, Smedegaard, Jørgen S., Lauritzen, Torsten, Christiansen, Jens S.
Format: Artigo
Jezik:Inglês
Izdano: Diabetes Technology Society 2007
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2769649/
https://ncbi.nlm.nih.gov/pubmed/19885138
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki